| 臺大學術典藏 |
2022-01-27T07:34:25Z |
Association of Bicipital Peritendinous Effusion with Subacromial Impingement: A Dynamic Ultrasonographic Study of 337 Shoulders
|
Chang K.-V.; WEI-TING WU; Özçakar L. |
| 臺大學術典藏 |
2021-01-22T04:24:51Z |
Association of Bicipital Peritendinous Effusion with Subacromial Impingement: A Dynamic Ultrasonographic Study of 337 Shoulders
|
Chang K.-V.;Wei-Ting Wu;?z?akar L.; Chang K.-V.; WEI-TING WU; Özçakar L. |
| 國立臺灣大學 |
2016 |
Association of BIM Deletion Polymorphism With Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Patients With Lung Adenocarcinoma
|
Wu, Shang-Gin; Liu, Yi-Nan; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 余忠仁; 吳尚俊; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:37:45Z |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Wu, Shang-Gin;Liu, Yi-Nan;Yu, Chong-Jen;Yang, Pan-Chyr;Shih, Jin-Yuan; Wu, S.-G. and Liu, Y.-N. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; 余忠仁;吳尚俊;施金元; Wu, Shang-Gin; Chong-Jen Yu; Wu, Shang-Gin; Liu, Yi-Nan; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Pan-Chyr; Shih, Jin-Yuan; Shih, Jin-Yuan |
| 臺大學術典藏 |
2016 |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Wu S.-G.;Liu Y.-N.;Yu C.-J.;Yang P.-C.;Jin-Yuan Shih; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2016 |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:21Z |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:00:19Z |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y. |
| 國立成功大學 |
2024-09 |
Association of biomarkers with response to first-line (1L) vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in advanced head and neck squamous cell carcinoma (HNSCC): Results from KEYVIBE-005
|
Seo;S;Calderon;B;Chou;H-H;Hsu;C-H;Salman;P;Ghiringhelli;F;Ozyilkan;O;Rojas;C, I.;Sendur;M, A. N.;Tourneau, Le;C;Yen;C, J.;Shapira-Frommer;R;Rha;S, Y.;Zhang;Y;Chen;C;Pena;C, E.;Keenan;T;Chen;Y;Dettman;E;Robinson;A, G. |
| 國立成功大學 |
2023 |
Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis
|
Chen, P.-W.;Su, H.-Y.;Tu, Y.-K.;Wu, C.-H.;Yeh, J.-I.;Chen, L.-Y.;Peng, C.C.-H.;Loh, C.-H.;Huang, Huang H.-K.;Lin, S.-M. |
